跳转至内容
Merck
  • The efficacy of bromides, stiripentol and levetiracetam in two patients with malignant migrating partial seizures in infancy.

The efficacy of bromides, stiripentol and levetiracetam in two patients with malignant migrating partial seizures in infancy.

Epileptic disorders : international epilepsy journal with videotape (2011-03-12)
Milena Djuric, Ruzica Kravljanac, Gordana Kovacevic, Jelena Martic
摘要

The syndrome of malignant migrating partial seizures in infancy is a devastating, age-specific, epileptic encephalopathy, which still presents an aetiological, pathophysiological and therapeutic problem. In this study, we present two patients who were diagnosed with the disease, based on electroclinical symptoms. The patients were treated with a combination of sodium bromide, stiripentol and levetiracetam. The first patient unequivocally responded, following a course of ineffective conventional drugs, and the second, who was diagnosed and treated immediately, showed a more significant therapeutic response. Antiepileptic drugs, previously reported to be beneficial in case reports, when given concomitantly, may substantially reduce the number and severity of seizures, without influence on psychomotor development. [Published with video sequences].

材料
货号
品牌
产品描述

Sigma-Aldrich
溴化钠, ACS reagent, ≥99.0%
Sigma-Aldrich
溴化钠, ReagentPlus®, ≥99%
Sigma-Aldrich
溴化钠, ≥99.99% trace metals basis
Sigma-Aldrich
溴化钠, BioUltra, ≥99.0% (AT)
Sigma-Aldrich
司替戊醇, ≥98% (HPLC)
Sigma-Aldrich
溴化钠, BioXtra, ≥99.0%
Supelco
密度标准品 1251kg/m3, H&D Fitzgerald Ltd. Quality